Prognosis
Glaxo Gets Ready for Next Pandemic After Covid Vaccine Stumble
- Drugmaker in talks with governments to build vaccine hubs
- Company expects two Covid-19 shots to be authorized this year
This article is for subscribers only.
GlaxoSmithKline Plc fell behind in the Covid-19 vaccine race, but now the drugmaker is working to make sure it’s on the front lines of the next pandemic.
The British pharma giant is talking with the U.K. and other governments about building facilities to bring vaccine development and production onshore before the next crisis, said Roger Connor, its vaccines chief. The labs would offer a range of vaccine technologies to tackle deadly viruses of the future, he said in an interview.